Risks for sudden cardiac and undetermined cause of death among people with HIV in the reprieve primary cardiovascular prevention trial

By sjmartinez • May 28, 2025

deFilippi C, Awwad A, Bloomfield GS, Weir IR, Ribaudo H, Zanni MV, Fichtenbaum CJ, Malvestutto CD, Aberg JA, Diggs MR, Chu SM, Paradis K, MacArthur RD, Pilotto J, Marks K, Van Dam C, Wilkin A, Currier JS, Zhao S, Wiviott SD, Lu MT, Douglas PS, Grinspoon S. Risks for sudden cardiac and undetermined cause of death among people with HIV in the reprieve primary cardiovascular prevention trial. AIDS. 2025 May 23. doi: 10.1097/QAD.0000000000004243. Epub ahead of print. PMID: 40424543.

Tags: electrocardiography, HIV, Infectious Diseases, Publications, Sudden cardiac death

Rapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review

Tieosapjaroen W, Williams E, Johnson CC, Baptista Da Silva C, Barr-DiChiara M, Rodolph M, Ingold HL, Schmidt HA, Prochazka M, Msimanga B, Lastrucci C, Peralta[...]

HLA Associations Differ by Ethnicity and Aquaporin-4 Antibody Status in Patients With Neuromyelitis Optica Spectrum Disorders

Niederschweiberer M, Panagiotaropoulou G, Fernandez-Viña MA, Montero-Martin G, Osoegawa K, Behne M, Franke A, Lieb W, Jarius S, Wildemann B, Schindler P, Otto C, Paul[...]

Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV

Hoffman R, Brummel S, Pinilla M, Malonga G, Chinula L, Stranix-Chibanda L, Machado ES, Naik S, Rathore MH, Pilotto J, Masheto G, Stringer JSA, Shapiro[...]